Blogopmaak
DCRT at workshop of the DARTER COST Action
No less than three DCRT coordinators actively contributed to the workshop of the Delivery of Antisense RNA Therapy (DARTER) COST Action that took place from July 19-21. DARTER is a network that aims to foster and facilitate antisense oligonucleotide research in Europe by achieving consensus on which model systems to use to improve delivery and study safety and toxicity of oligonucleotide therapies. COST Actions are funded by the cooperation of science and technology (COST. These networks are open to new participants also after the network has initiated. For more information on DARTER look on the antisenserna website.
During the workshop Willeke van Roon-Mom presented on delivery to brain and cell and animal model systems to test this. Rob Collin presented on delivery to the eye and the development of antisense oligonucleotide therapies for genetic retinal diseases. Finally, Annemieke Aartsma-Rus presented in the “negative results” session. DARTER and DCRT strongly believe that it is important to publish also about hypotheses and ideas that turned out not to work. Sharing these findings will avoid unnecessary duplication of work. Furthermore, hypotheses that are disproven also advance science.
published on Jul 29, 2021
Two new DCRT papers have been published online
Team DCRT went for its annual outing to Leiden's escape rooms
N=1 Collaborative is looking for communication trainees
PhD Position in treatment-response fluid biomarkers for ASO treatments
Short report of the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam
DCRT travel grants awarded to 3 PhD students
Dr Marlen Lauffer, a senior researcher at the Dutch Center for RNA Therapeutics, was invited to give a talk at the Genomics England research summit in London on the 9th of July. She presented DCRT's work on the identification of genes and diseases and guidelines for patient selection.
Our paper on patient selection guidelines for ASO-based treatments has been published in Human Mutation!
A special cake for Bianca Zardetto to celebrate the acceptance of her article in Human Mutation
DCRT at the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam